Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

blood_tests_pic

Blood tests taken within 24 hours of a traumatic brain injury can predict whether a patient will die, or survive with serious disability

August 12, 2022 Medical Communications

The tests’ results are available within minutes and will be useful in helping trauma ward staff and surgeons to decide …
News
booster

ONS figures show rapid decrease in people with higher COVID-19 antibody figures

August 12, 2022 Medical Communications

The amount of UK residents with higher levels of COVID-19 antibodies is falling, ONS statistics show.
News

F2G announce development and commercialisation for rare antifungal treatment

August 5, 2022 Medical Communications

F2G, a clinical-stage biopharmaceutical company, has announced that it can now soon bring a fourth antifungal class to the market. …
News

Societal CDMO wins tech transfer and production contract for HIV drug candidate

August 5, 2022 Medical Communications

Societal CDMO, a contract development and manufacturing organisation (CDMO) has been selected to provide CDMO services to support the ongoing …
News

NICE recommend new early targeted treatment for breast cancer

July 22, 2022 Medical Communications

Abemaciclib (Verzenios) has been approved by the NICE to treat some people with breast cancer that has a high-risk of …
News

£70 million in fines for pharma firms that overcharged NHS

July 22, 2022 Medical Communications

The CMA has found that Pfizer and Flynn charged unfairly high prices for phenytoin sodium capsules for over four years, …
News

Otsuka receives positive CHMP opinion for lupus nephritis treatment

July 22, 2022 Medical Communications

The CHMP has adopted a positive opinion relating to the use of Lupkynis (voclosporin) in combination with mycophenolate mofetil for …
News

Cancer Research UK agreement to advance cancer immunotherapy candidate

July 22, 2022 Medical Communications

Cancer Research UK and Sosei Heptares have announced the signing of an agreement to bring Sosei Heptares’ cancer immunotherapy drug …
News
alina-grubnyak-tevgmmapfxk-unsplash

FDA approval for neurostimulation device to treat diabetic neuropathic pain

July 15, 2022 Medical Communications

DyAnsys has received FDA approval for its First Relief device, a wearable device monitoring pulses of a low-level electrical current …
News

Step strategy effective in treating diabetic eye disease

July 15, 2022 Medical Communications

An NIH-funded clinical from the DRCR Retina Network suggests that a specific step strategy for patients with diabetic macular edema …
News

FDA approves new treatment for rare tumour

July 15, 2022 Medical Communications

The FDA has approved crizotinib for adult and paediatric patients aged 1 year and older with unresectable, recurrent, or refractory …
News

Japanese study suggests parasitic worms could deliver anti-cancer therapies

July 8, 2022 Medical Communications

Researchers from Osaka University have released details on how they discovered a unique potential treatment method for cancer: parasitic worms.The …
News

NICE recommends Nivolumab for invasive urothelial cancer

July 8, 2022 Medical Communications

NICE has published final draft guidance recommending nivolumab for treating some people with invasive urothelial cancer at a high risk …
News

New funding announced to support future dementia research

July 8, 2022 Medical Communications

The NIHR has introduced £11.8 million in funding for promising early career researchers to pursue dementia research. The institute, working …
News

Scientists discover key to hepatitis A replication

July 8, 2022 Medical Communications

UNC School of Medicine scientists discovered the key to hepatitis A virus (HAV) replication. They also found an oral compound …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026